Article Details
Retrieved on: 2024-11-25 22:59:25
Tags for this article:
Click the tags to see associated articles and topics
Summary
Boston Scientific's acquisition of Intera Oncology, focusing on MedTech, enhances cancer treatment capabilities with the Intera 3000 pump for liver tumors linked to colorectal cancer, using floxuridine and highlighting HAI therapy's growing oncology interest.
Article found on: www.medtechdive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here